Influenza Medicines Approved in the EU (EMA)

• 25medicines authorised in the EU (authorised now)

Each number has its full source under its own list below.

• 20Aug2026

  Aujemflu

  Active substance: A/(H1N1)-like virus antigen;A/(H3N2)-like virus antigen;B (Victoria lineage)-like virus antigen

  EMEA/H/C/006692
• 20Apr2026

  mCombriax

  Active substance: single-stranded, 5’-capped messenger RNAs (mRNAs) produced using a cell-free in vitro transcription from the corresponding DNA template, encoding seasonal infl…

  EMEA/H/C/006472
• 30Mar2026

  Supemtek

  Active substance: A/California/07/2009 (H1N1)pdm09-like strain (A/California/07/2009);A/Texas/50/2012 (H3N2)-like strain (A/Texas/50/2012);B/Brisbane/60/2008-like strain (B/Bris…

  EMEA/H/C/006674
• 9Jan2026

  VacPertagen

  Active substance: recombinant pertussis toxin;filamentous haemagglutinin

  EMEA/H/C/006304
• 15Nov2024

  Flucelvax

  Active substance: A/Missouri/11/2025 (H1N1)pdm09-like strain (A/Tasmania/318/2025, CVR-351);A/Darwin/1415/2025 (H3N2)-like strain (A/Tasmania/787/2025, CVR-388);B/Pennsylvania/1…

  EMEA/H/C/006532
• 15Nov2024

  Fluad

  Active substance: type A (H1N1) strain;type A (H3N2) strain;type B strain;A/Missouri/11/2025 (H1N1)pdm09-like strain (A/Missouri/11/2025, IVR-279);A/Darwin/1454/2025 (H3N2)-like…

  EMEA/H/C/006538
• 3Jun2024

  Fluenz

  Active substance: influenza virus (live attenuated);A/Missouri/11/2025 (H1N1)pdm09 - like strain (A/Switzerland/6849/2025, MEDI 400592);A/Darwin/1454/2025 (H3N2) - like strain (…

  EMEA/H/C/006514
• 19Apr2024

  Celldemic

  Active substance: Influenza virus A/turkey/Turkey/1/2005 (H5N1) NIBRG-23 strain, HA surface antigen

  EMEA/H/C/006052
• 19Apr2024

  Incellipan

  Active substance: Influenza virus A/turkey/Turkey/1/2005 (H5N1) NIBRG-23 strain, HA surface antigen

  EMEA/H/C/006051
• 9Oct2023

  Zoonotic Influenza Vaccine Seqirus

  Active substance: A/Astrakhan/3212/2020 (H5N8)-like strain (CBER-RG8A) (clade 2.3.4.4b)

  EMEA/H/C/006375
• 15Sep2023

  Lyfnua

  Active substance: gefapixant

  EMEA/H/C/005476
• 7Jan2021

  Xofluza

  Active substance: Baloxavir marboxil

  EMEA/H/C/004974
• 16Nov2020

  Supemtek Tetra (previously Supemtek)

  Active substance: Influenza A virus subtype H1N1 haemagglutinin, recombinant;Influenza A virus subtype H3N2 haemagglutinin, recombinant;Influenza B virus Victoria lineage haemag…

  EMEA/H/C/005159
• 26Apr2019

  Dectova

  Active substance: zanamivir

  EMEA/H/C/004102
• 20May2016

  Pandemic influenza vaccine H5N1 AstraZeneca (previously Pandemic influenza vaccine H5N1 Medimmune)

  Active substance: reassortant influenza virus (live attenuated) of the following strain: A/Vietnam/1203/2004 (H5N1) strain

  EMEA/H/C/003963

Source: European Medicines Agency, Centrally authorised human medicines (EPAR), authorised now. Retrieved 12 Nov 2026.

• Flu and pneumonia death rate

• OTC medicines
• Respiratory
• Infectious diseases
• Vaccines